MARK A GOLDSMITH, Director at Constellation Pharmaceuticals, holds 810.85K shares in Revolution Medicines (Ticker: RVMD), holds 89.86K shares in Constellation Pharmaceuticals (Ticker: CNST).

See the Hottest Stocks Based on Insider Trading >

MARK A GOLDSMITH
Constellation Pharmaceuticals (CNST)
Director

Ranked #55,781 out of 98,909 Corporate Insiders

Profitable Transactions

6 out of 11 Profitable Transactions

Average Return

-2.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

RVMD

A breakdown of MARK A GOLDSMITH's holdings

See the Top Stocks by Insiders

Insider Roles

Revolution Medicines
(RVMD)

President & CEO, Director

Roles that MARK A GOLDSMITH holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Revolution Medicines
(RVMD)

Rating:Informative Buy

Date:Oct 24, 2023 - Today

Return:+77.20%

The most profitable trade made by MARK A GOLDSMITH

See the Latest Stocks Traded by Insiders

MARK A GOLDSMITH's Trading History

CNST

Constellation Pharmaceuticals

Mar 08, 2021

―

Uninformative Buy

23.23K

$3.05M

RVMD

Revolution Medicines

Apr 12, 2024

President & CEO, Director

Uninformative Sell

619.40K

$30.14M

List of latest transactions for each holding click on a transaction to see MARK A GOLDSMITH's performance on stock

See All Insider Trading from Today

MARK A GOLDSMITH insider profile FAQ

What is the percentage of profitable transactions made by MARK A GOLDSMITH?

The percentage of profitable transactions made by MARK A GOLDSMITH is 55%.

What is the average return per transaction made by MARK A GOLDSMITH?

The average return per transaction made by MARK A GOLDSMITH is -2.10%.

What stocks does MARK A GOLDSMITH hold?

MARK A GOLDSMITH holds: CNST, RVMD stocks.

What was MARK A GOLDSMITH’s latest transaction?

MARK A GOLDSMITH latest transaction was an Uninformative Sell of $619.40K.

What was MARK A GOLDSMITH's most profitable transaction?

MARK A GOLDSMITH’s most profitable transaction was an Informative Buy of RVMD stock on October 24, 2023. The return on the trade was 77.20%.

What is MARK A GOLDSMITH's role in Constellation Pharmaceuticals?

MARK A GOLDSMITH's role in Constellation Pharmaceuticals is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

MARK A GOLDSMITH Insider Profile

MARK A GOLDSMITH Constellation Pharmaceuticals (CNST)Director